Relx Plc Stock Price, News & Analysis

LexisNexis Risk Solutions has appointed Valentina Isakina as Executive Vice President and Chief Strategy Officer, reporting to CEO Mark Kelsey. In this role, Isakina will oversee strategic direction and corporate development initiatives, focusing on global growth and innovation.

Isakina brings over 20 years of global experience in strategy, transformation, and innovation. Her previous roles include senior advisor to the Office of Tony Blair, managing director at JobsOhio, VP of corporate strategy at Nationwide Insurance, and consulting positions at McKinsey, Bain, and Milliman. She holds an MBA from Cornell, a Master's in Actuarial Science, and a BBA from Georgia State University, along with CFA certification.

This strategic appointment reinforces LexisNexis Risk Solutions' commitment to advancing its vision and enhancing industry-leading capabilities in the data and analytics sector.

LexisNexis Risk Solutions' fifteenth annual True Cost of Fraud Study reveals escalating fraud challenges in North American ecommerce and retail. US merchants face $4.61 costs per $1 of fraud, while Canadian merchants experience $4.52.

Mobile transactions, including digital wallets and peer-to-peer payments, account for 33% of fraud costs in the US and 41% in Canada. US ecommerce reports 53% of fraud costs from online purchases and 30% from mobile channels. The study, surveying 569 fraud executives, highlights that 63% of businesses experience increased customer churn due to fraud, while 64% report reduced conversion rates.

Notable concerns include that 41% of North American merchants still rely on manual fraud prevention processes. Customer friction remains a critical challenge, with poor user experience driving 36-37% of transaction abandonment in US retail and ecommerce during new account creation.

LexisNexis Risk Solutions has appointed Glenn Prager as Executive Director of Government Risk Solutions. Prager, with over 20 years of experience in public and private sectors, brings expertise in combating fraud, waste, and abuse in government programs.

Prager's background includes serving as Inspector General for Arizona, roles at the U.S. Department of Justice's Office of Inspector General, and the Center for Medicare and Medicaid Services (CMS). He will work across key markets including the U.S. Department of Health and Human Services, State and Local Medicaid Departments, and Inspector General Offices.

The appointment reinforces LexisNexis Risk Solutions' commitment to protecting government program integrity and public funds through advanced technology and analytics.

LexisNexis Risk Solutions has achieved the #2 position in Chartis Research's Financial Crime & Compliance50 (FCC50) rankings for 2025, advancing two places from its previous ranking. The company received three distinguished category awards:

• Innovation Award for contextual transaction screening (LexisNexis Firco Continuity solution)
• Innovation Award for its orchestration platform (LexisNexis RiskNarrative)
• Recognition for identity verification capabilities, including the IDVerse acquisition

The rankings highlight the company's comprehensive suite of financial crime compliance solutions, including screening tools, platforms, transaction monitoring, and identity verification solutions. The awards were announced at Chartis' FCC50 virtual event and the 1LoD Financial Crime Summit in New York City.

LexisNexis Risk Solutions has launched LexisNexis Flyreel for Claims, an AI-powered property claims inspection solution designed for U.S. home insurance carriers. The technology enables homeowners to conduct self-guided property inspections using their smartphones, streamlining the First Notice of Loss (FNOL) process.

The solution addresses key industry challenges including workforce shortages, rising claims volumes, and increasing loss adjustment expenses. Key features include:

• Cost reduction through decreased reliance on onsite adjusters
• Consumer-driven mobile inspection tool
• AI-powered virtual property inspections with high-resolution video
• Automated claims investigations
• SDK integration capabilities for insurers' apps

According to their recent study, 71% of homeowners prefer mobile inspections over traditional in-person visits, indicating strong market demand for this technology.

LexisNexis Risk Solutions, a RELX company, has completed its acquisition of IDVerse, an AI-powered document authentication and fraud detection solutions provider. IDVerse, founded in Australia and launched in 2018, will be integrated into LexisNexis' Business Services segment.

IDVerse's technology leverages deep neural networks to verify identity documents and perform biometric matching, capable of authenticating over 16,000 types of identity documents globally. The solution will be available within LexisNexis' RiskNarrative platform, IDU, and as a standalone solution in the Dynamic Decision Platform later this year.

The integration aims to enhance LexisNexis' multi-layered identity verification capabilities, particularly in combating AI-generated fraud and deepfakes. The combined solution will offer improved risk insights, consumer protection, and financial inclusion while helping organizations maintain optimal risk posture.

LexisNexis Risk Solutions reports continued strong growth in U.S. auto insurance shopping, with an 18% increase in consumer shopping in 2024 compared to 2023. The Q4 2024 showed a 26% increase in shopping activity, while new policy growth reached 17.7%. 45% of policies-in-force were shopped at least once in the last 12 months as of December 31, 2024.

The market saw a notable trend shift in late 2024, with shopping growth outpacing new business as carriers implemented rate increases across multiple states. New York and Hawaii emerged as outliers, showing below-average performance. The holiday season witnessed a larger-than-usual drop in new policies, attributed to increased rate parity across carriers limiting consumers' ability to find lower rates.

Looking ahead to 2025, insurers face challenges from recent natural disasters, including Southern California wildfires and winter storms, which may lead to further rate increases. Marketing and pricing strategies are becoming important differentiators for insurers balancing customer acquisition and retention.

WEPACK 2025, organized by RX, announces an 'Overseas Packaging Enterprises' Business Study Tour to China' from April 6-13, 2025. The event highlights China's significant 23% share of the global packaging market, with sales revenue of $266.1 billion.

The tour features six customized routes across East, South, and North China, focusing on intelligent factories, lean management, food container processing, digital packaging, and large-format carton forming. Each route accommodates 30 participants and includes factory visits, demonstrations, forums, and networking events.

The program begins with the World Corrugated Forum in Shanghai, followed by WEPACK 2025 participation and specialized factory tours. Nearly 10,000 overseas companies from 110+ countries are expected to attend, representing various packaging sectors including corrugated boxes, folding carton boxes, printing, and food packaging.

LexisNexis Risk Solutions has announced the launch of new research-ready, real-world healthcare datasets designed to accelerate research timelines and reduce costs. The solution uses referential-based tokenization to create blended, patient-level datasets that are standardized and research-ready.

The data blends combine multiple datasets including:

• Care Delivery Insights with medical, pharmacy, and lab claims
• Financial insights on total care costs
• Social determinants of health (SDOH) factors
• Mortality Insights updated weekly

The integrated datasets provide a longitudinal view across all care settings and populations, enabling researchers to identify distinct patient populations, reduce potential biases, and support proactive monitoring of high-risk populations. This initiative aims to help research teams create more holistic and unbiased datasets to uncover health disparities and develop personalized treatments.